A DEDICATED ANNUAL INDUSTRY GUIDE PUBLISHED BY MANAGING IP

BONUS DISTRIBUTION TO THE 2011 BIO INTELLECTUAL PROPERTY

COUNSELS’ FALL CONFERENCE & COMMITTEE MEETING

LIFE SCIENCESIPFOCUS2011

2

LIFE SCIENCESIPFOCUS2011

INTRODUCTIONManaging IP is pleased to be supporting the Biotech Industry Organization’s(BIO) bi-annual Intellectual Property Counsels’ Conference & CommitteeMeeting and we will publish our unique industry guide, The Life SciencesFocus, to coincide with this key industry meeting in the Fall of 2011.

As a dedicated annual guide, the Life Science Focus will provide our influen-tial global readership of senior executives and IP counsel across the Life sci-ences industries with an invaluable review of the major IP issues and latestregulatory developments affecting their strategic planning.

Your firm is invited to participate.

OPPORTUNITIES TO PARTICIPATEThe Life Science Focus will be published in September 2011 and distributedwith the October 2011 edition of Managing IP. It will combine exclusivemarket analysis with focused jurisdictional updates to provide Managing IP’sinfluential global audience (see pages 5 and 6) with a definitive review ofthe key developments around the world.

The coverage will be split into two sections:

SECTION 1 – IN-HOUSE AND REGULATORSThe first section will bring together features from Managing IP’s editorialteam, in-house counsel and international industry organisations discussingthe major international trends. Limited advertising positions are available inthis section – please see page 3 for full details.

SECTION 2 – IP DEVELOPMENTSThis section will comprise exclusive articles from leading firms. These willprovide comprehensive discussion of the major IP issues affecting life sci-ences companies around the world, plus pro-active strategic advice for theirIP counsel and senior executives – for details of chapter sponsorship, andthe full editorial structure, please see pages 3 and 4.

AT A GLANCE❍ Managing IP’s annual supplement dedicated

to the latest IP issues across the Life Sciencesindustries

❍ Practical editorial coverage for in-house coun-sel and private practitioners

❍ Combination of editorial features fromManaging IP’s journalists with indepth analysisfrom leading firms

❍ Published with the October 2011 edition ofManaging IP

❍ Up to 11,849 readers per edition based uponthe audited readership survey● North America 49%● Europe 33%● Asia-Pacific 15%● 66% CorporatePlease see page 5 for full details

❍ The Life Science Focus will be distributed atthe following conferences in 2011*● LES US & Canada Annual Meeting,

San Diego, October 16-20 2011● AIPLA Annual Meeting, Washington DC,

October 20-22 2011● BIO Intellectual Property Counsels’ Fall

Conference & Committee Meeting, New York, November 2-4 2011

● FICPI 13th Open Forum, Rome, November 14-18 2011

*Please note conference attendance is subject tochange

❍ Electronic distribution through the 20,000 monthly unique visitors to www.managingip.com and the 14,000+recipients of the Managing IP’s weekly e-newslettersPlease see the following pages for full details

❍ Exclusive profiling and sponsorship optionsavailablePlease see the following pages for full details

CONTACTSMANAGER - NORTH ASIABryce Leung, +852 2842 6937 bryce.leung@euromoneyasia.comMANAGER - SOUTH ASIAVictoria Pawsey, +852 2842 6965victoria.pawsey@euromoneyasia.comNORTH AMERICA Tom StDenis, +1 212 224 3412tstdenis@iinvestor.netPUBLISHER - LATIN AMERICA & SERVICE PROVIDERSAlissa Rozen, +1 212 224 3673 arozen@euromoneyny.comMANAGER - EUROPE, MIDDLE EAST & AFRICAAli Jawad, +44 20 7779 8682ajawad@managingip.com

THE OPTIONS AND COSTS, IN EUROS, ARE AS FOLLOWS

FULL PAGE Full colour: €5,165

HALF PAGEFull colour: €3,855

QUARTER PAGE Full colour: €2,545

OPTION 1: DISPLAY ADVERTSThe first section in The Life Science Focus willcomprise new editorial features fromManaging IP’s team of journalists.

This editorial will include Q&A features andindustry discussions with prominent in-houseand regulator figures. The section will explorethe diverse IP issues affecting Life Sciencescompanies around the world and will attractconsiderable attention from the publication’sinfluential international readership.

To benefit from the targeted exposure this willreceive, a limited number of advertising posi-tions will be available alongside the editorialsection.

GOLD SPONSOR❍ A 2,000 word chapter within the publication covering your

chosen topic/jurisdiction

❍ A full page premium cover position colour advert.

❍ A full page black and white advert alongside your article

❍ Up to two biographies of contributing authors (including photographs)

❍ The firm’s name and logo on the front cover of the publication

❍ The full hard copy and electronic distribution as outlined on pages 5& 6 of the proposal

COST: €10,000

SINGLE CHAPTER SPONSOR❍ A 2,000 word chapter within the publication covering your

chosen topic/jurisdiction

❍ A full page black and white advert alongside your article

❍ Up to two biographies of contributing authors (including photographs)

❍ The firm’s name on the front cover of the publication

❍ The full hard copy and electronic distribution as outlined on pages 5 & 6 of the proposal

COST: €7,000 PER MAJOR TOPIC/JURISDICTION

COPY DEADLINE SEPTEMBER 2 2011

RESERVATION DEADLINE AUGUST 1 2011

3

LIFE SCIENCESIPFOCUS2011

PARTICIPATION DETAILSOPTION 2: SPONSORSHIPFirms can reserve the exclusive position to sponsor the Life Sciences Focusand contribute one or more chapters to the publications. Both regional/industry overviews or dedicated jurisdictional topics are available (pleasesee the next page for the editorial structure).

MANAGING IP FACTS❍ GLOBAL REACH

❍ 66% CORPORATE

❍ THE AVERAGE NUMBER OF READ-ERS PER COPY IS 4.6*

❍ MANAGING IP IS A SUBSCRIPTION-LED MAGAZINE – THIS SETS USAPART FROM MANY PUBLICATIONSTHAT DISTRIBUTE ON A PURELYNONREQUESTED MAIL BASIS.

SOURCES: *Calculated from the July 2010 IPSOS MORIreadership survey. Please note: the figure for future edi-tions will vary.

EDITORIAL STRUCTUREThe aim of the editorial structure is to encompass those IP issues offundamental importance to Managing IP’s international readership of in-house counsel and senior executives at the major Life Sciences companies,while highlighting the latest regulatory and legislative developments thathave taken place, or will take place, in the near future.

Below are some suggested topics that firms may cover from a global,regional or jurisdictional level.

REGIONALFirms with multi-jurisdictional capabilities may wish to cover a specificindustry focused topic from a regional or international perspective – fourgeneral suggested topics are suggested below:

• Pharmaceutical legislation (either regional or as a comparison betweenEU and US)

• Asian overview – the development of the industry in the region

• Parallel trade issues – international issues and comparisons

• Regional/international licensing – regional discussions

JURISDICTIONAL CHAPTERSThe basis of these chapters is to highlight recent IP developments, theirimplications for the life sciences industry and the optimum business strate-gies to implement. To ensure a level of consistency between chaptersauthors are suggested to cover the following:

• Ownership of IP – how does ownership arise? (including inventorsrights)

• Patentability of pharmaceutical and biotech inventions – what claimsare permissible?

• Know-how and trade secrets – what protection is available?

• Pharmaceutical patent term extension – what is available?

• Data protection – what exclusivity is available and how does it apply?

• Enforcement of IP rights – what relief is available from courts and alter-native options?

• Experimental use exception – is defence available for experimentsand/or trials?

• Parallel imports – what rules apply?

• Protection of product brands – what major issues may arise?

EXTENDEDDISTRIBUTIONCONFERENCESThe maximize exposure for participatingfirms, the Life Science Focus will be at the following conferences in 2011*:

❍ BIO INTELLECTUAL PROPERTYCOUNSELS’ FALL CONFERENCE ANDCOMMITTEE MEETING, NEW YORK,NOVEMBER 2-4 2011

❍ LES US & CANADA ANNUAL MEETING,SAN DIEGO, OCTOBER 16-20 2011

❍ AIPLA ANNUAL MEETING,WASHINGTON DC, OCTOBER 20-22 2011

❍ FICPI 13TH OPEN FORUM, ROME,NOVEMBER 14-18 2011

*Please note that conference attendance is subject tochange

4

LIFE SCIENCESIPFOCUS2011

ELECTRONIC DISTRIBUTIONThe Life Sciences IP Focus will be displayed in the open access areaof www.managingip.com which reaches over 20,000 unique visitorsper month1.

The Life Sciences IP Focus will also be featured on Managing IP’s e-newsletters which are sent to over 14,000 recipients each week2.

Please see the following page for example recipients.

The statistics are as follows:

E-NEWSLETTERS SUBSCRIBERS BY OCCUPATION3

E-NEWSLETTERS SUBSCRIBERS BY REGION3

■ 31% North America■ 37% Europe■ 25% Asia-Pacific■ 6% Rest of the world■ 1% Unknown

■ 6% Academic Institution/Student■ 7% Consultancy■ 34% Corporate/Financial Institution■ 6% Govt./Industry Association■ 44% Law firm/IP Agency■ 3% Other

COMPANY** REGION**

■ 15% Asia-Pacific

■ 33% Europe

■ 49% North America

■ 3% Rest of the World

■ 4% Government/Academic

■ 66% Corporate

■ 25% Private practice

■ 5% Other

MAGAZINE READERSHIP STATISTICS*The Life Science IP Focus will be a special supplement to the October 2011 edition of the magazine therefore reachingManaging IP’s readership of 11,849 individuals world-wide*.

SOURCES:*The readership figure is based upon a survey conducted in July 2010 and independently audited by IPSOS MORI the international media consultancy. Ata 95% confidence level, Managing IP has a readership of between 10,200 and 13,499 readers. **Based on analysis from Managing IP July/August 2010 subscriptions file and controlled circulation. Please note; the exact figures for future editions may vary

1Average number of unique visitors per month from December 2010 to May 2011 as recorded by Google Analytics.2Correct as of 31/5/2011. 3Correct as of 19/07/2010 based on analysis of 10% of MIP Week subscribers, select-ed at random and conducted by Euromoney Institutional Investor PLC, please note future subscriber lists will vary.

5

LIFE SCIENCESIPFOCUS2011

6

LIFE SCIENCESIPFOCUS2011

3M CompanyAgrium Air LiquideAlcatel Lucent Alcon Laboratories Alibaba.comAnderson Mori & TomotsuneApple Arla Foods Astrazeneca Bae Systems Bajaj Auto Baker & MckenzieBank Of Tokyo Mitsubishi UFJBarclays GroupBardehle PagenbergBayer BHP BillitonBird & BirdBombardier Transportation BP International Bridgestone CorporationBrinks Hofer Gilson & LioneBritish American Tobacco Cadbury GroupCambridge DisplayTechnologyCanon CCPIT Patent & TrademarkLaw OfficeChevron

ChipworksClarke ModetClifford ChanceCPA GlobalDanone DiageoDolby Laboratories Dr Reddy’s Laboratories Dyson Technology EGYPEpson Ericsson European Patent OfficeF Hoffman-la Roche Fangda PartnersFerrari Finnegan HendersonFish & Richardson France TelecomFreehillsFreshfields Bruckhaus DeringerFujifilm Manufacturing General Electric Giga-byte Technology Gill Jennings & Every GlaxosmithklineGowlingsGriffith HackHitachi Howrey HSBC Holdings

Imperial Tobacco Intellectual Property OwnersAssociationIntellectual VenturesIkea Holding Services IP StrategiesJack Daniels Properties Japan External TradeOrganizationJardine MathesonJohnson & JohnsonKenyon & Kenyon Kimberley Clark Knobbe Martens Olson &BearKodakLall Lahiri & SalhotraLancaster Group Levi Strauss & Co LG CorporationLiu Shen & AssociatesLonely Planet PublicationsL’Oreal LVMH Fashion GroupMaiwald Patentanwalts Mallesons Stephen JaquesManchester United Marks & ClerkMars IncorporatedMastercard InternationalMelbourne IT

Millipore CorporationMorrison & Foerster NASANECNokia CorporationNovamont NovartisNovopharm Oblon Spivak Oxford Gene TechnologyParamount PicturesCorporationPearson Education Pepsico Pernod Ricard PetrobrasPetronasPhilip MorrisPhilips International Procter & Gamble Red Bull Remfry & SagarResearch In MotionRichemont International Rouse & Co InternationalRoyal Bank Of ScotlandSanoma CorporationSanyo Electric SchlumbergerShell International Sony Computer Entertainment

Sony Ericsson MobileCommunicationsSpoor & FisherSpruson & FergusonStandard Chartered BankSyngenta Seeds Tetra Pak The Chanel Company The Coca Cola CompanyThe Dow Chemical CompanyThinkfire Services UnileverInternational TradeCommissionUS Patent & Trademark OfficeVia Licensing CorporationVisa Wellcome TrustWIPOWorld Trade OrganizationWragge & Co YKK Europe Zippo Manufacturing

SELECTED SUBSCRIBERS TO MANAGING IP*

3M Company, Trademark counselAdidas International, Assistant generalcounselAGIP, Senior managerAmerican Express, Senior legal managerAmgen, Senior counselArsenal Football Club, IP and licensinglegal advisorAstraZeneca, Legal managerAutodesk, IP counselBank of America, Associate generalcounselBarclays, IP legal counselBATMark Limited, Trade mark managerBauer, Patent attorneyBBC, Intellectual property managerBiogen, Inc, Vice presidentBMW AG, Legal counselBoeing, Patent professionalBP, Trade mark managerBT, IPR licensing executiveCA, Inc, Legal specialistChanel, Intellectual property counsel China Telecom, Associate managerChivas Brothers, Head of IPCisco Systems, DirectorCSL Limited, Trade mark attorneyDaimlerChrysler, Patent administratorDaimlerChrysler AG, Chief trademarkcounselDatamonitor, Trademark directorDiageo, IP counselDole, Legal managerDr Reddy’s Laboratories, AssociatedirectorEastman Chemical Company,Intellectual capital analystElectrolux, Attorney

Eli Lilly and Company, Senior directorElizabeth Arden, Trademark managerEricsson, DirectorFedEx, Intellectual property principalFerrari, Legal counselGlaxoSmithKline, Director and trademark counselGreen Cross International, Head ofadministrationGucci Group, Senior legal counselHonda, AttorneyHSBC Holdings, Information managerHuawei, Deputy directorIBM, Senior attorneyICI, Senior patent aattorneyInfineon, ExecutiveInfosys, Technical specialistIntel, Senior counselJohn Deere, Senior counselJohns Hopkins Tech Transfer, PatentcounselJ P Morgan Chase, Vice presidentKimberly-Clark, IT consultantKodak, AttorneyLG Electronics, IP specialistL’Oreal, LawyerLucas Automotive, European patentcounselMarconi, Corporate lawyerMicrosoft, IP development managerMitsubishi Electric Corporation,Assistant managerMonsanto, Business analystMotion Picture Association, DirectorMotorola, Senior counsel NASA, Director, Innovative partnershipsNational Basketball Association,Intellectual property manager

NEC, ManagerNestle, Head of intellectual property NHS Innovations, CEONissan Technical Center, EngineerNokia, Strategic marketing specialistNortel Networks, Corporate lawyerNovartis, IP policy coordinatorNovartis International, IP litigationmanagerOSIM, DirectorOxford Instruments, Group IP coordinatorPenguin Group, Contracts executivePepsiCo China, Senior attorneyPernod Ricard, General counselPetronas, IP managerPfizer Global Pharmaceuticals, GlobalsecurityPhilip Morris International, Senior counselPhilips, Legal counselPratt & Whitney Corp, Intellectualproperty counselProcter & Gamble, IP counselQualcomm, Senior paralegalRanbaxy, Senior managerRaytheon Company, CounselRed Hat, Legal affairs managerRenault, Patent engineerRPX Corporaiton, ManagerSamsung Electronics, Managersandisk, Investigator Sanofi-aventis, Regional business managerSchering-Plough, VP patentsSchlumberger, Manager - IP enforcementSeiko Epson, GMShell Technology, Manager IPSiemens, IP counselSime Darby Technology Centre, Strategy

and business Development executiveSony Ericsson, Legal counselStandard Bank, ManagerSylvania, Legal managerSyngenta, General counsel TAEUS International, Chief technologyofficerTaylor Made Golf Company, IP attorneyThe Body Shop International, Group IPcounselThe Rangers Football Club, Head ofbrand protectionThe Swatch Group, Trademark counselThe Walt Disney Company, IP managerTiffany & Co, IP attorneyToyota Motor, Legal managerTravelex, ManagerTyco International, General counselUnilever, Lead scientistVictoria Secret, DirectorVirgin Enterprises, IP lawyerVisa, Legal managerVolkswagen, Corporate counselWal-Mart Stores, Intellectual propertymanagerWarner Bros, AttorneyWIPO, Legal officerWm Wrigley Jr Company, Chief trademark counselWyeth, Patent counselXerox, Partner managementYamaha Motor Europe, General legalcounselZippo Manufacturing, General counsel

**SOURCE: MIP Week subscriber listdownload 19/07/10. Please note thatfuture subscriber lists will vary.

SELECTED RECIPIENTS OF MIP E-NEWSLETTERS**

*SOURCE: Managing IPactive subscriber databaseJuly/August 2010. Please notethat future subscriber lists willvary.